ESP Block for Pain After Kidney Stone Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness of a special type of pain relief, the erector spinae (ESP) block, after kidney stone surgery. Researchers aim to determine if it reduces morphine use and pain compared to a simple saline injection. Participants will receive either the ESP block with ropivacaine (a numbing medicine) and dexamethasone (an anti-inflammatory) or just a saline injection. This study may suit adults scheduled for non-emergency kidney stone surgery who do not regularly use opioids. As an unphased trial, it offers participants the chance to contribute to innovative pain management research.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have been using opioids for more than 90 days in the past year, you cannot participate.
What prior data suggests that the erector spinae block is safe for reducing pain after kidney stone surgery?
Research has shown that the erector spinae plane (ESP) block is generally safe for managing pain after kidney stone surgery. Studies have found that patients receiving an ESP block experience good pain relief with few side effects. In one study with 68 patients, the ESP block was well-tolerated.
The anesthetic used in the block, ropivacaine, is safe when used properly. Dexamethasone, a steroid added to reduce swelling, is also commonly used and has a good safety record. Reports suggest that these treatments together effectively manage pain without major side effects.
While the ESP block works well, its pain-relieving effects are usually short-term. Overall, the treatment is considered safe, and side effects are rare.12345Why are researchers excited about this trial?
Researchers are excited about the ESP Block with ropivacaine and dexamethasone for post-kidney stone surgery pain because it offers a targeted approach to pain management. Unlike opioids, which are commonly used and can lead to significant side effects and dependency, this method involves a local anesthetic technique that directly numbs the nerves near the spine, providing pain relief right where it's needed. Additionally, combining ropivacaine with dexamethasone may enhance and prolong the pain relief effect without the systemic impact of traditional pain medications. This innovative approach aims to reduce reliance on opioids, offering a potentially safer and more effective pain management solution.
What evidence suggests that the ESP block is effective for reducing pain after kidney stone surgery?
In this trial, participants in the ESP Group will receive an erector spinae plane (ESP) block with ropivacaine and dexamethasone. Research shows this method can effectively reduce pain and lessen the need for painkillers after kidney stone surgery. One study found that patients who received an ESP block used fewer opioids and experienced less pain post-surgery. Another study confirmed that this block provides significant pain relief soon after surgery. Additionally, the ESP block has demonstrated long-lasting pain control after these procedures. These findings suggest that the ESP block might help manage pain and reduce opioid use in patients recovering from kidney stone surgery.678910
Who Is on the Research Team?
Jason Buehler, MD
Principal Investigator
University of Tennessee Medical Center
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 who are having non-emergency kidney stone surgery (percutaneous nephrolithotomy) during weekdays. They must be able to understand and explain the consent process, and women of childbearing age need a negative pregnancy test.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo percutaneous nephrolithotomy and receive either an ESP block or a control block
Immediate Post-operative Monitoring
Participants are monitored for opioid consumption and pain levels using VAS scores in the first 24 hours post-surgery
Follow-up
Participants are monitored for recovery quality and opioid use at 24 hours, 48 hours, 7 days, and 30 days post-surgery
What Are the Treatments Tested in This Trial?
Interventions
- Dexamethasone
- Erector Spinae Plane Block
- Ropivacaine 0.5% Injectable Solution
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Tennessee Medical Center
Lead Sponsor